Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

GM&C Life Sciences Fund

Status
ACTIVE
Global HQ
Manchester, United Kingdom
Countries of investment
  • United Kingdom
Investment stages
  • Seed
  • Series A
Industries
  • MedTech
  • Biotechnology
About
The GM&C Life Sciences Fund is dedicated to supporting life-science startups in North-West England, particularly those with translational potential—meaning the ability to move from research and development into real-world applications. This fund focuses on sectors such as medtech, diagnostics, and therapeutics, and prioritizes ventures that have credible clinical development paths. With a focus on capital efficiency and long-term growth, the GM&C Life Sciences Fund aims to help these companies reach the market and become leaders in their fields.
Min check size
$100K
Max check size
$20M
Fund size
NPS

Investment Thesis

GM&C Life Sciences Fund’s thesis is to back innovative life-science companies in North-West England that demonstrate translational and commercial potential. It targets early-stage ventures with robust R&D pipelines, credible management, and scalable technologies in medtech, therapeutics, and diagnostics. The fund aims to catalyze regional innovation by helping companies bridge the gap between research and clinical or market application.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Managed by industry veterans with deep expertise in life sciences and healthcare investing, combining scientific and commercial backgrounds to support biotech innovation.

Team

Duncan Cameron – Investment Director

Professor Rob Carroll – Director

Dr. Tony Flinn – Partner

Kevin D'Silva – Senior Advisor

Dr. Gareth King – Senior Advisor

Laurence Vaughan – Chief Technology Officer

Dr. David Whitcombe – Senior Advisor

Nick Wright – Investment Director

Sarah Cooper – Portfolio Manager

Anne Freeman – Senior Advisor

Corinne Lawrence – Senior Associate

Natalie Melvin – Associate

Hamish Graham – Partner.

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp